| Subject: | FDA Announces Recall of B. Braun Medical Inc. Normal Saline Flush Syringes |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 14 Sep 2007 - 11:00 pm |
| The FDA has announced that B. Braun Medical Inc. has issued a recall of Normal Saline Flush Syringes with lot numbers ending in "SFR" due to an increase in customer complaints of particulate matter in the saline. This voluntary recall affects:Normal saline 3mL in 12mL syringes, designated by product code 513584Normal saline 10mL in 12mL syringes, designated by product code 513587Between June 11 and July 18 of this year, B. Braun Medical Inc. distributed approximately 33,000 units of... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|